enterprise

NextBio provides pharmaceutical and biotechnology companies, commercial and non-profit R&D organizations and academic institutions a completely integrated solution that enables them to dramatically increase return on investment (ROI) on billions of dollars worth of experiments. NextBio's highly secure enterprise package allows companies to unlock the value of internal research by linking to hundreds of billions of dollars worth of outside experiments carefully processed by the NextBio scientific team and made seamlessly available through the NextBio search engine. The NextBio solution breaks down silos within R&D organizations and creates synergies as internal proprietary data and publicly available experiments are analyzed together in an integrated research environment.

SaaS Application

NextBio is sold as a SaaS (software-as-a-service) application. As such, there is no software to download and no behind-the-firewall installations. The NextBio solution can be deployed inside any organization within a matter of minutes.

Data Integration - Bridging Silos

A key value of the NextBio enterprise solution is how easy it is for experimental results within an organization to be shared between different therapeutic groups and scientific silos. An organization's internal data can be loaded into NextBio through our simple on-line import tool or in bulk using NextBio's special data import API. NextBio gives each organization the right to assign one or multiple "administrators" who control access to internal experimental data by individual users.

Value Chain

NextBio delivers value to different stake holders within any organization:

• Research Scientists (biologists, chemists, toxicologists) - Query NextBio to validate or generate novel hypotheses prior to investing in new experiments. Correlate results from high-throughput and high-content screening assays to understand compounds of interest. Validate biomarker activities and identify new targets.
• Clinical Scientists - Mine the aggregate experimental and clinical data within NextBio to facilitate translational research efforts and elucidate alternative indications for existing compounds.
• Program Directors - Assemble your team's collective knowledge and find connections between data from diverse therapeutic areas to drive program success.
• Computational Experts - Explore experimental results and correlate these to a wealth of public and private data within NextBio to assist scientists with the interpretation of their studies.

Support & Services

The NextBio enterprise solution includes on-site visits and support to help researchers within an organization maximize the value of NextBio. Support and service levels are customized to fit the individual enterprise's support needs. For more details, please contact a NextBio sales representative by clicking here.

Subscribing to NextBio

NextBio is used daily by some of the world's leading research enterprises, including Eli Lilly, Johnson & Johnson, Scripps Research Institute, Regeneron, Burnham Institute for Medical Research, UC Davis, Stanford, Celgene, Genzyme, and many others. Please contact us at enterprisesales@nextbio.com to learn more about how you can subscribe to an enterprise account.